These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 20221893)

  • 21. Extracellular matrix metalloproteinase inducer (EMMPRIN) is increased in human left ventricle after acute myocardial infarction.
    Nie R; Xie S; Du B; Liu X; Deng B; Wang J
    Arch Med Res; 2009 Oct; 40(7):605-11. PubMed ID: 20082877
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gene expression levels of matrix metalloproteinases in human atherosclerotic plaques and evaluation of radiolabeled inhibitors as imaging agents for plaque vulnerability.
    Müller A; Krämer SD; Meletta R; Beck K; Selivanova SV; Rancic Z; Kaufmann PA; Vos B; Meding J; Stellfeld T; Heinrich TK; Bauser M; Hütter J; Dinkelborg LM; Schibli R; Ametamey SM
    Nucl Med Biol; 2014 Aug; 41(7):562-9. PubMed ID: 24853402
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The expression and significance of activator protein-1 and matrix metalloproteinases in the human heart post acute myocardial infarction].
    Xie SL; Wang JF; Nie RQ; Yuan WL; Li F; Lin YQ
    Zhonghua Nei Ke Za Zhi; 2009 Mar; 48(3):205-7. PubMed ID: 19576087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early events of overused supraspinatus tendons involve matrix metalloproteinases and EMMPRIN/CD147 in the absence of inflammation.
    Attia M; Huet E; Gossard C; Menashi S; Tassoni MC; Martelly I
    Am J Sports Med; 2013 Apr; 41(4):908-17. PubMed ID: 23404084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Matrix metalloproteinases in patients with myocardial infarction and percutaneous revascularization.
    Eckart RE; Uyehara CF; Shry EA; Furgerson JL; Krasuski RA
    J Interv Cardiol; 2004 Feb; 17(1):27-31. PubMed ID: 15009768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of proinflammatory alleles in longevity and atherosclerosis: results of studies performed on -1562C/T MMP-9 in centenarians and myocardial infarction patients from Sicily.
    Nuzzo D; Vasto S; Balistreri CR; Di-Carlo D; Listì F; Caimi G; Caruso M; Hoffmann E; Incalcaterra E; Lio D; Caruso C; Candore G
    Ann N Y Acad Sci; 2006 Nov; 1089():496-501. PubMed ID: 17261792
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin 18 and extracellular matrix metalloproteinase inducer cross-regulation: implications in acute myocardial infarction.
    Xie SL; Chen YY; Zhang HF; Deng BQ; Shu XR; Su ZZ; Lin YQ; Nie RQ; Wang JF
    Transl Res; 2015 Mar; 165(3):387-95. PubMed ID: 25267095
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased matrix metalloproteinase-8 and -9 activity in patients with infarct rupture after myocardial infarction.
    van den Borne SW; Cleutjens JP; Hanemaaijer R; Creemers EE; Smits JF; Daemen MJ; Blankesteijn WM
    Cardiovasc Pathol; 2009; 18(1):37-43. PubMed ID: 18402833
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum levels of matrix metalloproteinases 2 and 9 in patients with acute myocardial infarction.
    Šímová J; Škvor J; Slovák D; Mazura I; Zvárová J
    Folia Biol (Praha); 2013; 59(5):181-7. PubMed ID: 24280140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Matrix metalloproteinases and mesangial remodeling in light chain-related glomerular damage.
    Keeling J; Herrera GA
    Kidney Int; 2005 Oct; 68(4):1590-603. PubMed ID: 16164636
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relevance of matrix metalloproteinases and their inhibitors after myocardial infarction: a temporal and spatial window.
    Vanhoutte D; Schellings M; Pinto Y; Heymans S
    Cardiovasc Res; 2006 Feb; 69(3):604-13. PubMed ID: 16360129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of matrix metalloproteinases in patients with Wegener's granulomatosis.
    Bjerkeli V; Halvorsen B; Damås JK; Nordøy I; Yndestad A; Aukrust P; Frøland SS
    Ann Rheum Dis; 2004 Dec; 63(12):1659-63. PubMed ID: 15547092
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relation of matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio in peripheral circulating CD14+ monocytes to progression of coronary artery disease.
    Brunner S; Kim JO; Methe H
    Am J Cardiol; 2010 Feb; 105(4):429-34. PubMed ID: 20152234
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of matrix metalloproteinases, tissue inhibitor of matrix metalloproteinase-1, and extracellular metalloproteinase inducer by interleukin-17 in human periodontal ligament fibroblasts.
    Wu Y; Zhu L; Wei H; Peng B
    J Endod; 2013 Jan; 39(1):62-7. PubMed ID: 23228259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The plasminogen-MMP system is more activated in the scar than in viable myocardium 3 months post-MI in the rat.
    Gaertner R; Jacob MP; Prunier F; Angles-Cano E; Mercadier JJ; Michel JB
    J Mol Cell Cardiol; 2005 Jan; 38(1):193-204. PubMed ID: 15623436
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Implication of interleukin 18 in production of matrix metalloproteinases in articular chondrocytes in arthritis: direct effect on chondrocytes may not be pivotal.
    Dai SM; Shan ZZ; Nishioka K; Yudoh K
    Ann Rheum Dis; 2005 May; 64(5):735-42. PubMed ID: 15834055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of matrix metalloproteinases and their inhibitors in the left ventricular myocardium of patients with aortic stenosis.
    Fielitz J; Leuschner M; Zurbrügg HR; Hannack B; Pregla R; Hetzer R; Regitz-Zagrosek V
    J Mol Med (Berl); 2004 Dec; 82(12):809-20. PubMed ID: 15558223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Elevation of matrix metalloproteinases and interleukin-6 in the culprit coronary artery of myocardial infarction.
    Suzuki H; Kusuyama T; Sato R; Yokota Y; Tsunoda F; Sato T; Shoji M; Iso Y; Koba S; Katagiri T
    Eur J Clin Invest; 2008 Mar; 38(3):166-73. PubMed ID: 18257779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of matrix metalloproteinases 1, 2, and 9 and tissue inhibitor of matrix metalloproteinase-1 in chronic venous insufficiency.
    Saito S; Trovato MJ; You R; Lal BK; Fasehun F; Padberg FT; Hobson RW; Durán WN; Pappas PJ
    J Vasc Surg; 2001 Nov; 34(5):930-8. PubMed ID: 11700497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Matrix metalloproteinase expression and activity in human airway smooth muscle cells.
    Elshaw SR; Henderson N; Knox AJ; Watson SA; Buttle DJ; Johnson SR
    Br J Pharmacol; 2004 Aug; 142(8):1318-24. PubMed ID: 15265805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.